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Introduction
　Exfoliative toxins (ETs) from Staphylococcus aureus 
cause bullous impetigo and a severe blistering disease in 
neonates, generally called staphylococcal scalded skin syn-
drome (SSSS).1,2 A previous study using an animal model of 
neonatal mice demonstrated that the site of action of ETs is 
desmosome3, which connects adjacent granulosa cells and 
becomes split on blister formation. Although ETs have long 
been considered as toxins and no proteolytic activity has 
been found, their amino acid sequence similarity4,5 and ter-
tiary structure6,7 have strongly suggested that they belong to 
the chymotrypsin-like family of serine proteases and cleave 
peptide bonds C-terminally adjacent to acidic residues, Glu 
and Asp.
　S. aureus produces four serologically distinct ETs, i.e., 
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ETA, ETB, ETC and ETD.8,9 Most et+ strains isolated from 
human impetigo carry eta (68.9%) and etb (30.0%), while 
strains etc+ (1.8%) and etd+ (0%) were scarcely isolated.10 By 
analogy to pemphigus foliaceus, Amagai et al.11,12 have 
shown that desmoglein 1 (Dsg1), a desmosome transmem-
brane constituent, is a target of ETA and ETB, and cleavage 
of Dsg1 causes blisters. ETs cleave human and mouse Dsg1 
at a single site at Glu381-Gly382 located in the junction region 
between extracellular domains 3 and 4.13 In addition, it has 
been reported that α- and β-melanocyte-stimulating hor-
mones were cleaved by ETA and ETB.14 However, protease 
activity of ETs other than toward these substrates has not 
been shown to date, and thus the precise molecular mecha-
nism of specific cleavage and proteolytic activity of ETs 
remain to be elucidated. Furthermore, it was reported that 
only 30-40% of S. aureus strains giving rise to SSSS in 
Europe and the United States produce ETs,15,16,17 and there is 
very little literature available on the epidemiology of ET-
producing S. aureus strains, due to the lack of a suitable and 
standardized in vitro assay.18 Therefore, such assay system 
is keenly required to elucidate whole mechanism of S. 
aureus infectious diseases causing blister.
 　It has been known that S. aureus produces various patho-
genic factors，in which Glu-specific endopeptidase, GluV8, 
is one of the most abundant and potent proteases mediating 
inflammatory reaction.19 Most human isolates possess the 
gene of GluV8.20 GluV8 peptidase possess the Glu-specific 
substrate specificity and efficiently degrades Dsg1.13 There-
fore, the reason why ETs, but not GluV8, are responsible for 
blister formation at diseased areas remains unknown.
　In the present study, to elucidate relationship between the 
proteolytic and biological activities of ETA, we employed 
recombinant techniques for preparation of wild type ETA 
expressed in Escherichia coli, because the ambiguity of the 
previous data has been mainly caused by the purity of the 
ET preparations.14 For instance, contamination of GluV8 in 
either native or recombinant ETA specimen prepared from 
S. aureus may significantly influence the data due to its 
marked activity. Besides wild type ETA molecules possess-
ing mature and pro-mature sequences, a single-amino acid-
mutant substituted an essential Ser to Ala and an α1 region 
(Ala42-Tyr56)-deletion-mutant were expressed. Their prote-
olytic activities were measured in vitro using synthetic pep-
tidyl substrates, and these activities were compared with 
their exfoliative activities examined with a mouse model.
Materials and Methods
 
Materials. Benzyloxycarbonyl (Z)-LLE-, succinyl (Suc)-AE-, 
and Suc-AAA-4-methylcoumaryl-7-amide (MCA) were ob-
tained from the Peptide Institute (Osaka, Japan). LE-, LD-, 
Z-LLQ-MCA were synthesized by Thermo Fisher Scientif-
ic. Recombinant GluV8 proform (pro-GluV8) was expressed 
in Escherichia coli and converted into a mature form (mat-
GluV8) by thermolysin treatment as previously reported.21
Construction of expression plasmids. S. aureus JT1 (eta+) 
was isolated from a region of impetigo.22 A DNA fragment 
encoding the full length of eta was amplified by PCR using 
S. aureus JT1 genomic DNA with a set of primers (5ʼ-TGAG-
GATCCATGAATAATAGTAAAATTATT-3ʼ and 5ʼ-TATG-
GATCCCTCATTTTTCTCGTTTATAATG-3 ,̓ in which the 
BamH1 sites are underlined). After BamH1 cleavage, a re-
sultant fragment was inserted into the site of pQE60, pro-
ducing pQE60-ETA. Expression plasmids deleting Met1-
Ala38 (designated Glu39-ETA) and Met1-Gly57 (Val58-ETA) 
were generated by PCR from pQE60-ETA with primers 
(5ʼ-GAAGTTTCAGCAGAAGAAATAAAAAAC-3ʼ for Glu39-
ETA) or (5ʼ-GTCAATGCATTTAATTTACCAA-3ʼ for Val58-
ETA) and an antisense primer (5ʼ-CATGGTTAATTTCTC-
CTCTTTAATGA-3ʼ). The Ser233Ala substitution was 
introduced by PCR-based mutagenesis21 using a set of prim-
ers (5ʼ-GCGGGATCAGGTATATTTAATTCA-3ʼ and 5ʼ-ATTTC-
CCGGAACTGTAAATCCATAG-3ʼ). E. coli XL1-blue was 
transformed with the plasmids.
Induction and purification of recombinant ETAs. E. coli 
was cultured in Luria-Bertani broth in the presence of 50 
μg/ml of ampicillin. Recombinant ETAs were induced with 
0.2 mM isopropyl β-D-1-thiogalactopyranoside, purified on 
Talon metal affinity resin (Clontech) as previously report-
ed21 and then dialyzed against PBS. Recombinant proteins 
were sterilized by passing through a 0.45-μm membrane 
filter and aliquots were stored at -80 ̊C until being used.
Protease activity. A highly sensitive detection technique is 
indispensable to measure the proteolytic activity of ETA, 
and thus we used fluorescent substrates, i.e., commercially 
available and synthesized peptidyl-MCAs carrying Glu at 
the P1 position. Protease activity was measured according 
to the previous report.21 In brief, 0.2 ml of the reaction mix-
ture composed of 50 mM Tris/HCl (pH 8.0) and 10 or 40 μM 
MCA-peptide was preincubated at 37 ˚C for 5 min. The re-
action was started by an addition of recombinant ETA (4 
μg) or mature GluV8 (0.25 μg). Fluorescence intensity with 
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excitation at 380 nm and emission at 460 nm was measured 
chronologically or at 60 min after starting reaction. As 
negative controls, the same amounts of pure bovine serum 
albumin (New England Biolabs) were used instead of ETA 
or GluV8.
Animal model. The study protocol received approval from 
the Ethics Committee of Nagasaki University Graduate 
School of Biomedical Science (approval no. 0911170797). 
Neonatal ddY mice within 16 h after birth (weight 1.3-1.9 g) 
were subcutaneously injected in the back with either ETA or 
GluV8 (10 or 20 μg) in PBS, or PBS alone. All mice were 
maintained at 26-28˚C and covered with wet cotton to 
prevent dryness. They were graded on appearance and 
tactile examination.11,23 Mice were euthanized at the end 
of the 24-h observation period. Thereafter, tissues were 
carefully excised, fixed with 10% formaldehyde, and 
embedded in paraffin, then sections were stained with 
hematoxylin and eosin. To quantitate exfoliative activity of 
recombinant ETA and GluV8 molecules, we defined an 
intact index, and at least five sites of each section (933 μm 
in average) were examined. Intact index was calculated as 
follows: 
　Intact index (%) = length of adhesion area/length of total 
　area appearing in a histochemical section × 100 
Statistics. Differences of proteolytic activity toward the 
three substrates were calculated by two-way repeated-
measures ANOVA, or comparisons between two groups 
were assessed using Studentʼs t-test.
SDS-polyacrylamide gel electrophoresis (PAGE) and N-
terminal sequencing. Proteins were separated by PAGE in 
the presence of 0.1% (w/v) of SDS with a polyacrylamide 
concentration of 11% (w/v), then stained with Coomassie 
Brilliant Blue. For N-terminal sequencing, separated 
proteins were transferred to a Sequi-Blot membrane (Bio-
Rad) and stained with Coomassie Brilliant Blue. The 
N-terminal sequences of stained bands were determined 
with a model Procise 49XcLC proteinsequencer (Applied 
Biosystems) as previously described.21
Results
Expression, purification, and N-terminal sequences of 
recombinant ETAs
　N-terminal 23 (Met1-Ala23) and subsequent 15 amino acid 
residues (Phe24-Ala38) of ETA were shown to correspond to 
prepro- and pro-sequences, respectively.8 When full-length 
ETA was expressed in E. coli as a C-terminal His6-tagged 
protein, the N-terminal sequence was found to be Phe-Val-
Ile-Asn-Asp-Glu-Leu-Met-Gln-Lys, which corresponded to 
Phe24-Lys33 of ETA (Fig. 1), hence this molecule carried pro-
sequence and was designated Phe24-ETA. The cleavage at 
the Ala23-Phe24 bond could be mediated by E. coli signal 
peptidase. Glu39-ETA, a mature form, and ETA with dele-
tion of the first α helix (α1, Ala42-Tyr56) (designated Val58-
ETA) were also expressed to study the inhibitory effects of 
the pro-sequence and α1 region on the activity. In Val58-
ETA, Gly57 was additionally deleted, since the α-amino 





























































Figure 1. Schematic presentation and SDS-PAGE findings of ETA. (a) His110, Asp158, and Ser233 (asterisks) are the residues to 
form the catalytic triad conserved in serine proteases. Dots indicate the substitution of active Ser233 to Ala. N-terminal pro- and 
α1 regions are shown by hatched and gray boxes, respectively. His6-tag (closed boxes) is attached at the C-terminus. (b) Puri-
fied ETAs (0.3 μg) were separated on SDS-PAGE. Lane M, low-molecular-weight marker.
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associated with the γ-carboxyl group of glutamic acid of a 
substrate.21,24 The N-terminal sequences of these truncated 
moieties were confirmed to be Glu39-Val-Ser-Ala-Glu-Glu44 
and Val58-Asn-Ala-Phe-Asn-Leu-Pro-Lys-Glu-Leu67, respec-
tively. Additionally, Phe24- and Glu39-ETAs with a single 
amino acid substitution of Ser233Ala were expressed (Fig. 
1). Purified Phe24-, Glu39-, and Val58-ETAs were found to 
be migrated as 33-, 32-, and 31-kDa bands, respectively, on 
SDS-PAGE, which were comparable to their calculated 
molecular masses (29,911, 28,157, and 25,807, respectively).
Peptidase activity of recombinant ETAs
　We measured the peptidase activity using recombinant 
ETAs with LLE-MCA (Fig. 2). Hydrolysis of LLE-MCA 
was observed in both Phe24-ETA and Glu39-ETA, and 
completely suppressed in the presence of 1 mM Pefabloc, a 
potent irreversible serine protease inhibitor. When Ser233 
was substituted to Ala, these mutants of Phe24- and Glu39-
ETA S233A molecules exhibited no hydrolysis. Further-
more, Val58-ETA deleting the α1 region also lost the 
activity, suggesting that the region is conversely required 
for proteolytic activity.
　In order to define the substrate specificity, the proteolytic 
activities of Phe24- and Glu39-ETAs were determined with 
five additional substrates (Fig. 3). Following LLE-MCA, 










































Figure 2. Proteolytic activity of ETA toward LLE-MCA. (a) Proteolytic activities of Phe24- and Glu39-ETAs in the presence 
and absence of 1 mM Pefabloc were measured with 10 μM LLE-MCA at 37 ˚C for 1 h. Lines were obtained by linear regression 
of the data starting from value zero at time zero. Continuous line, Phe24-ETA; dashed line, Phe24-ETA with Pefabloc; dashed 
spaced line, Glu39-ETA; dotted line; Glu39-ETA with Pefabloc. (b) The peptidase activities of Phe24-S233A-, Glu39-S233A- 
and Val58-ETAs were determined. Lines were obtained as above. Continuous line, Phe24-S233A-ETA; dashed line, Glu39-












































































Figure 3. Substrate specificity of ETA. Proteolytic activities of (a) Phe24- and Glu39-ETAs, and (b) mature GluV8 were determined 
with 40 and 10 μM peptidyl MCA substrates, respectively. Values are shown as means ± SD of triplicate samples. Representative 
results of three different experiments are shown. +P>0.05, Studentʼs t-test; *P=0.02, two-way repeated-measures ANOVA.
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whereas LLQ-, LD- and AAA-MCA were not hydrolyzed. 
The tendency of the substrate specificity (LLE > AE > LE) 
was identical to that of GluV8, though the specific activity 
of GluV8 was 36,000-fold higher than that of ETA. Thus, it 
was found that ETA is truly a Glu-specific serine endopep-
tidase, whose substrate specificity is basically identical to 
that of GluV8. 
　Noticeably, the hydrolyzing activities of Glu39-ETA for 
the three major substrates were consistently higher than 
those of Phe24-ETA, although the differences in the pepti-
dase activities between two recombinant ETAs were not 
significant (P=0.266, 0.088 and 0.304 for LLE-, AE- and LE-
MCA, respectively) (Fig. 3a). On the other hand, when data 
for the three substrates were calculated by two-way repeat-
ed-measures ANOVA, a significant difference (p=0.024) 
was noted between two ETAs.
Exfoliative activity of recombinant ETAs and GluV8
　The exfoliative activities of proteolytically active and 
inactive ETAs and GluV8 were evaluated using a mouse 
model. ETAs were injected subcutaneously into the dorsal skin 
of neonatal mice, then exfoliation was assessed 24 h later 
based on gross pathology (Table 1, Fig. 4). Intraepidermal 
blister formation and epidermolysis were induced by 
proteolytically active Phe24-ETA and Glu39-ETA, while 
the S233A mutants and Val58-ETA did not induce any 
symptoms. In histological observations of dorsal skin 
specimens, superficial intraepidermal blister formation without 
keratinocyte necrosis was also observed with Phe24-ETA 
and Glu39-ETA, but not with the S233A mutants or Val58-
ETA.
　When mice were injected with proGluV8, any changes 
were not detected in either gross or pathological observa-
tions of the skin, whilst mature GluV8 caused redness of the 
skin within 30 min after injection, and all mice (4/4) with 20 
μg and two of three mice with 10 μg of GluV8 died within 24 
h. Gross pathology and skin biopsy findings examined im-
mediately after death (21 h after injection) indicated no skin 
separation in mature GluV8-injected mice.
　The exfoliative activity of recombinant proteins was 
evaluated using intact index values (Fig. 4c): The activity 
was more potent with Glu39-ETA (11.6 ± 10.2%, n = 56) 
followed by Phe24-ETA (55.4 ± 27.6%, n = 46), while no 
apparent exfoliation was observed with proteolytically in-
active ETAs. Thus, the exfoliative activity of ETAs in the 
present mouse study was tightly associated with the prote-
olytic activity.








10 3/3 + -
20 8/8 + 46
Phe24-S233A-ETA 20 6/6 - 48
Glu39-ETA
10 3/3 + -
20 7/7 + 56
Glu39-S233A-ETA 20 6/6 - 48
Val58-ETA 20 4/4 - 22
pro-GluV8
10 2/2 - -
20 3/3 - 15
mature GluV8
10 1/3 - -
20 0/4 - 10
PBS - 4/4 - 22
Neonatal ddY mice within 16 h after birth (weight 1.3-1.9 g) were subcutaneously injected in the back with 
either ETA or GluV8 (10 or 20 μg) in PBS, or PBS alone, and assays were performed with each group in five 
separate experiments. *Epidermolysis was judged by touch with a finger to determine whether epidermis 
peeling had occurred. †Randomly selected 5-8 fields of vision in one section from each mouse were exam-
ined to calculate intact index (Fig. 4c).
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Figure 4. Exfoliative activities of ETA and GluV8. (a) ETA and GluV8 (20 µg) were injected subcutaneously into the dorsal 
skin of neonatal ddY mice. After 24 (ETA) or 21 h (mature GluV8), exfoliative activity was assessed by gross pathology. (b) 
Blister formation was assessed based on detachment of the cornified layer mainly due to acantholysis between the granular 
(arrow) and prickle cell (arrowhead) layers. Sections were stained with hematoxylin and eosin. Bar = 50 μm. (c) Exfoliative 
activity was quantified with intact index values (mean ± SD) calculated using 10-56 sites in each group in five separate 
experiments (see Table 1). *P<0.05, Studentʼs t-test.
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Discussion
　Although the specificity for Glu was suggested from the 
structural similarity of the active site to GluV8,6,7 proteolyt-
ic activity has not been measured for substrates other than 
Dsg111 and melanocyte-stimulating hormones.14 In the 
present study, Glu-specific endopeptidase activity was 
demonstrated with synthetic peptidyl substrates for the first 
time in vitro using E. coli-expressed recombinant ETAs, i.e., 
Phe24-ETA and Glu39-ETA. Using this in vitro measurement 
system and E. coli-expressed recombinant ETA mutants, we 
demonstrated that Ser233 is essential for the proteolytic 
activity in accord with previous reports showing that Ser233 
is indispensable for exfoliative activity.25,26 Furthermore, 
Val58-ETA deleting the α1 region exhibited no activity. 
This result suggests that the region is not a mere “lid” of the 
active site27 but conversely required for proteolytic activity.
　In addition, it is notable that examination using recombi-
nant E. coli-expressed ET molecules employed in this study 
is highly advantageous to assess their properties, since the 
possibility of contamination of GluV8 and/or other pyro-
genic factors is not completely excluded in native or recom-
binant ET preparations obtained from S. aureus strains. For 
instance, S. aureus strains carrying the gene encoding 
GluV8 are abundantly present in clinical isolates,18 and the 
GluV8 activity is 36,000-fold higher than that of ETA (Fig. 3). 
If an ET preparation contains a trace amount of GluV8, its 
proteolytic activity will be considered as that of ET. Further-
more, both ETA and ETB had been reported to be bacterial 
superantigens exhibiting mitotic activity and stimulating 
proliferation of T cell28,29,30 possibly due to contamination by 
S. aureus real superantigens. Contamination of superanti-
gen was also reported in a streptococcal peptidase, SpeB, 
fraction from Streptococcus pyogenes.31   
 　Comparison of the hydrolyzing activities for LLE-, LE-, 
AE-MCA and other MCA substrates demonstrated that sub-
strate specificity of ETA is indistinguishable from that of 
GluV8 (Fig. 3). The present results also indicate that the 
reason for apparent lack of in vitro protease activity is due 
to the extremely low peptidase activity of ETA toward 
substrates carrying a Glu residue at the P1 position. Indeed, 
the specific activity of ETA was 1/36,000 that of GluV8. More-
over, it should be notable that the more potent exfoliative 
activity of Glu39-ETA compared to Phe24-ETA was consis-
tent to higher peptidase activity of this molecule. 
　We initially considered the possibility that pro-sequence 
and α1 might interfere with access of a substrate peptide to 
the active site. However, Phe24-ETA exhibited both prote-
olytic and exfoliative activities, though they were lower 
than those of Glu39-ETA. These results suggest that the 
conversion of ETA from Phe24-ETA pro-form to Glu39-
ETA represents the maturation step of ETA mediated by an 
unknown S. aureus peptidase. Furthermore, the present 
results showed that α1 is essential for peptidase activity. 
Therefore, these findings do not support an interaction 
between the helical α1 region and loop 2, which acts as a 
“lid” for the S1 pocket,27 but suggest that α1 is involved in 
stability of formation of the enzyme pocket or in regulating 
the activity via interaction with a receptor molecule.7,27 A 
quantitative measurement of ETA peptidase activity in vitro 
should be critical for investigating the mechanism of 
impetigo or SSSS. For instance, the subtle difference in the 
peptidase activities between Phe24-ETA and Glu39-ETA 
was successfully demonstrated and was likely to be related 
to the significant difference in their exfoliative activities. 
　In conclusion, we demonstrated for the first time the pro-
teolytic activity of ETA in vitro using synthetic peptidyl 
substrates. Our results confirm that the peptidase activity of 
ETA is extremely low as compared with GluV8, while the 
potential of ETA enzymatic activity is directly related to the 
development of exfoliation of skin. 
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